63 items

New Eye Drops May Prevent a Common Cause of Blindness

June 29, 2020

Researchers at Columbia University Irving Medical Center have developed eye drops that could prevent vision loss after retinal vein occlusion, a major cause of blindness for millions of adults worldwide.

Researchers look to the eye for insights about the brain

June 23, 2020

Researchers seeking to unravel the mysteries of how our amazingly complex brains do what they do, often start with the eye. The retina, the light-sensing tissue at the back of the eye has long been a model for scientists to explore how the brain works.

National Eye Institute establishes office of regenerative medicine

June 18, 2020

The National Eye Institute (NEI) has established an office to accelerate progress in regenerative medicine for eye disease and vision disorders.

New gene therapy delivery system aims for precision

May 4, 2020

In a novel approach to gene therapy, scientists funded by the National Eye Institute (NEI) report using gold nanoparticles and light to target specific cells in mouse retina.

Florida Atlantic Scientists land NEI grant for tissue engineering approach

April 3, 2020

The Kantorow Laboratory and research program have been continually funded by the NIH’s National Eye Institute for almost two decades.

Therapy could improve, prolong sight in those suffering vision loss

March 13, 2020

Millions of Americans are progressively losing their sight as cells in their eyes deteriorate, but a new therapy developed by researchers at the University of California, Berkeley, could help prolong useful vision and delay total blindness.

Scientists successfully test new way to deliver gene therapy​

March 6, 2020

Researchers at Case Western Reserve University have used a unique method to safely deliver gene therapy to fight a rare, but irreversible, genetic eye disorder known as Stargardt disease.

Tech that detects cause of preemie blindness gets federal nod

January 30, 2020

An artificial intelligence algorithm that can detect a potentially devastating cause of childhood blindness better than most human experts has been granted breakthrough status by the FDA.

NIH launches first U.S. clinical trial of patient-derived stem cell therapy to replace and repair dying cells in retina

December 16, 2019

Researchers at the National Eye Institute (NEI) are launching a clinical trial to test the safety of a novel patient-specific stem cell-based therapy to treat geographic atrophy, the advanced “dry” form of age-related macular degeneration.

Joslin Researchers Uncover Protective Factor in Diabetic Eye Disease

July 3, 2019

Researchers at Joslin Diabetes Center have shown that a protein found in the eye can protect against and potentially treat diabetic eye disease.